DHG Pharmaceutical JSC (HOSE: DHG)

Market Cap	13.51T
Revenue (ttm)	4.96T
Net Income (ttm)	804.09B
Shares Out	130.75M
EPS (ttm)	6,149.98
PE Ratio	16.80
Forward PE	12.87
Dividend	7,500.00 (7.26%)
Ex-Dividend Date	Dec 24, 2024

Volume	10,100
Average Volume	19,300
Open	102,800
Previous Close	102,700
Day's Range	102,800 - 104,500
52-Week Range	98,500 - 125,900
Beta	0.54
RSI	46.60
Earnings Date	Jan 20, 2025

About DHG Pharmaceutical JSC

DHG Pharmaceutical Joint Stock Company, together with its subsidiaries, engages in the manufacture and sale of pharmaceutical products in Vietnam. The company offers antibiotic, analgesic and antipyretic, respiratory, nutrition, musculoskeletal, gastrointestinal and hepatobiliary, nervous and ophthalmic, cardiovascular and diabetic, and dermatology and beauty care products. It also manufactures and trades in dietary supplements and pharmaceuticals cosmetics. The company exports its products to approximately 20 countries. The company was founded...

• Industry: Pharmaceutical Preparations
• Founded: 1974
• Employees: 2,789
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: DHG

Financial Performance

In 2023, DHG Pharmaceutical JSC's revenue was 5.02 trillion, an increase of 7.26% compared to the previous year's 4.68 trillion. Earnings were 1.02 trillion, an increase of 6.31%.